Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

In8Bio Inc (INAB)

In8Bio Inc (INAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

In8Bio Inc 350 5th Avenue Suite 5330 New York NY 10118 USA

www.in8bio.com Employees: 18 P: 646-600-6438

Sector:

Medical

Description:

IN8bio Inc. is a clinical-stage biotechnology company. It focuses on developing therapies for the treatment of cancers, including solid tumors using allogeneic, autologous, and genetically modified gamma-delta T cells. The company's principal candidate includes INB-200, which are in clinical stage. IN8bio Inc. is based in New York.

Key Statistics

Overview:

Market Capitalization, $K 9,955
Enterprise Value, $K -1,165
Shares Outstanding, K 4,218
Float, K 3,564
% Float 84.50%
Short Interest, K 278
Short Float 6.59%
Days to Cover 1.00
Short Volume Ratio 0.44
% of Insider Shareholders 15.50%
% of Institutional Shareholders 92.05%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -30,440 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,850 K
EBIT, $ -21,050 K
EBITDA, $ -18,390 K

Growth:

1-Year Return -72.84%
3-Year Return -96.55%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.85 on 11/06/25
Next Earnings Date 03/12/26
Earnings Per Share ttm -5.39
EPS Growth vs. Prev Qtr 31.45%
EPS Growth vs. Prev Year 81.13%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 06/06/25

INAB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -147.21%
Return-on-Assets % -108.63%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.89
Book Value/Share 2.91
Interest Coverage -1.22
60-Month Beta -0.01
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar